Humanetics Corporation and Pharmaceutics International, Inc. (Pii) Announce Partnership in Support of BIO 300 Clinical Trials in COVID-19 Patients

NEXT STORY
Sorrento Announces FDA IND Filing Today for COVI-GUARD Neutralizing and High Potency Antibody Against SARS-CoV-2
PREV STORY
Biocept Expands Agreement with MultiPlan to Include COVID-19 Testing
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

-   New positive clinical and translational data for both lead agents -   Strong balance ...

author_avatar
NASDAQ Market News

Calithera Achieves Positive Topline Results in Randomized Phase 2 ENTRATA Study of Telaglenastat with Everolimus in Renal Cell Carcinoma

author_avatar
NASDAQ Market News

Cue Biopharma Reports Confirmed Partial Response (PR) in Ongoing Phase 1 Monotherapy Study of CUE-101 in Late Stage Second Line and Beyond Patients with HPV+ Recurrent/Metastatic Head and Neck Cancer

author_avatar
NASDAQ Market News